Geron reported $-236K in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Amgen USD 4.61B 777M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Cassava Sciences USD -11.17M 2.38M Mar/2026
Cytokinetics USD -181.23M 2.86M Mar/2026
Exelixis USD 251.34M 15.43M Mar/2026
Genmab DKK 260M 199M Dec/2025
Geron USD -236K 10.55M Mar/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Incyte USD 700.4M 376.22M Jun/2026
MacroGenics USD -33.44M 21.34M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Novavax USD 20.94M 100.32M Dec/2025